Is TRDA stock safe? | Glauxie AI

Q: Is TRDA stock safe?

Entrada Therapeutics, Inc. (TRDA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Dipal Doshi. Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform... Employees: 15,000.

Q: What are the risks of investing in TRDA?

Identify key risks of investing in TRDA — debt, competition, volatility, and sector headwinds.

Q: Is TRDA a good long-term investment?

Evaluate TRDA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does TRDA have?

Review TRDA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is TRDA stock safe?

🦉

Entrada Therapeutics, Inc. (TRDA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODipal Doshi

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead...

Key Executives

Name	Title
Dipal Doshi	Chief Executive Officer & Director
Jared Cohen	General Counsel
Karla MacDonald	Chief Corporate Affairs Officer
Kerry Robert	Senior Vice President of People
Kevin Healy	Senior Vice President of Regulatory Affairs
Kory James Wentworth	Chief Financial Officer & Treasurer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TRDA Profile Financials

What are the risks of investing in TRDA? Is TRDA a good long-term investment? How much debt does TRDA have?